Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.

Margine I, Martinez-Gil L, Chou YY, Krammer F.

PLoS One. 2012;7(12):e51559. doi: 10.1371/journal.pone.0051559. Epub 2012 Dec 7.

2.

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.

Vaccine. 2007 May 10;25(19):3871-8. Epub 2007 Feb 15.

PMID:
17337102
3.

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF 3rd, Glenn GM.

Vaccine. 2013 Sep 13;31(40):4305-13. doi: 10.1016/j.vaccine.2013.07.043. Epub 2013 Jul 26.

4.

One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.

Klausberger M, Wilde M, Palmberger D, Hai R, Albrecht RA, Margine I, Hirsh A, García-Sastre A, Grabherr R, Krammer F.

Vaccine. 2014 Jan 9;32(3):355-62. doi: 10.1016/j.vaccine.2013.11.036. Epub 2013 Nov 18.

5.

Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.

Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.

J Virol. 2015 Jul;89(14):7224-34. doi: 10.1128/JVI.00585-15. Epub 2015 May 6.

6.

Baculovirus-produced influenza virus-like particles in mammalian cells protect mice from lethal influenza challenge.

Tang XC, Lu HR, Ross TM.

Viral Immunol. 2011 Aug;24(4):311-9. doi: 10.1089/vim.2011.0016.

PMID:
21830902
7.

Protection of mice against pandemic H1N1 influenza virus challenge after immunization with baculovirus-expressed stabilizing peptide fusion hemagglutinin protein.

Yang E, Cho Y, Choi JA, Choi Y, Park PG, Park E, Lee CH, Lee H, Kim J, Lee JM, Song M.

J Microbiol Biotechnol. 2015 Feb;25(2):280-7.

8.
9.

Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.

Quan FS, Kim YC, Song JM, Hwang HS, Compans RW, Prausnitz MR, Kang SM.

Clin Vaccine Immunol. 2013 Sep;20(9):1433-9. doi: 10.1128/CVI.00251-13. Epub 2013 Jul 17.

10.

Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice.

Prabakaran M, Meng T, He F, Yunrui T, Qiang J, Lin RT, Kwang J.

Clin Vaccine Immunol. 2011 Sep;18(9):1582-5. doi: 10.1128/CVI.05114-11. Epub 2011 Jul 13.

11.

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.

Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.

Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.

12.

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.

López-Macías C, Ferat-Osorio E, Tenorio-Calvo A, Isibasi A, Talavera J, Arteaga-Ruiz O, Arriaga-Pizano L, Hickman SP, Allende M, Lenhard K, Pincus S, Connolly K, Raghunandan R, Smith G, Glenn G.

Vaccine. 2011 Oct 13;29(44):7826-34. doi: 10.1016/j.vaccine.2011.07.099. Epub 2011 Aug 2.

PMID:
21816199
13.

A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.

Wu CY, Yeh YC, Chan JT, Yang YC, Yang JR, Liu MT, Wu HS, Hsiao PW.

PLoS One. 2012;7(8):e42363. doi: 10.1371/journal.pone.0042363. Epub 2012 Aug 7.

14.

Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine.

Wu Q, Xiao S, Fan H, Li Y, Xu J, Li Z, Lu W, Su X, Zou W, Jin M, Chen H, Fang L.

Antiviral Res. 2011 Dec;92(3):493-6. doi: 10.1016/j.antiviral.2011.10.001. Epub 2011 Oct 12.

PMID:
22020305
15.

Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009.

Choi JY, Gwon YD, Kim JK, Cho YD, Heo YK, Cho HS, Choi TJ, Poo HR, Oh YK, Kim YB.

PLoS One. 2013 Nov 18;8(11):e80762. doi: 10.1371/journal.pone.0080762. eCollection 2013.

16.

Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity.

Kim MC, Lee YN, Hwang HS, Lee YT, Ko EJ, Jung YJ, Cho MK, Kim YJ, Lee JS, Ha SH, Kang SM.

Vaccine. 2014 Oct 7;32(44):5824-31. doi: 10.1016/j.vaccine.2014.08.030. Epub 2014 Aug 27.

17.

Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.

Pushko P, Pujanauski LM, Sun X, Pearce M, Hidajat R, Kort T, Schwartzman LM, Tretyakova I, Chunqing L, Taubenberger JK, Tumpey TM.

Vaccine. 2015 Sep 11;33(38):4975-82. doi: 10.1016/j.vaccine.2015.07.026. Epub 2015 Jul 21.

18.

Immunogenicity and safety of H1N1 influenza hemagglutinin protein expressed in a baculovirus system.

Na HN, Kim KH, Song MK, Park HL, Lee EY, Shim SH, Park S, Nam JH.

Microbiol Immunol. 2013 Sep;57(9):660-4. doi: 10.1111/1348-0421.12079.

19.

Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.

Ji X, Ren Z, Xu N, Meng L, Yu Z, Feng N, Sang X, Li S, Li Y, Wang T, Zhao Y, Wang H, Zheng X, Jin H, Li N, Yang S, Cao J, Liu W, Gao Y, Xia X.

Viruses. 2016 Apr 21;8(4):115. doi: 10.3390/v8040115.

20.

Characterization of the immune responses elicited by baculovirus-based vector vaccines against influenza virus hemagglutinin.

Hu ZP, Yin J, Zhang YY, Jia SY, Chen ZJ, Zhong J.

Acta Pharmacol Sin. 2012 Jun;33(6):783-90. doi: 10.1038/aps.2012.23. Epub 2012 May 7.

Supplemental Content

Support Center